Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
37
FDMT Quote, Financials, Valuation and Earnings
Last price:
$4.35
Seasonality move
:
-28.07%
Day range:
$4.19 - $4.41
52-week range:
$2.24 - $19.69
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
10,531.44x
P/B ratio:
0.43x
Volume:
275.9K
Avg. volume:
443K
1-year change:
-76.04%
Market cap:
$202M
Revenue:
$37K
EPS (TTM):
-$3.18
Earnings Data
Next earnings date for FDMT
Aug 08
2025
Most recent earnings per share
-$0.86
Beat by $0.00
(May 8/2025)
Consensus Estimate
-$0.86
(May 8/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
FDMT Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $522.8K | -- | -- | -$0.95 | -- |
| 08/08/2025 | Q2 | $522.8K | -- | -- | -$0.69 | -- |
| 05/08/2025 | Q1 | $446.3K | $14K | -$0.86 | -$0.86 | $0.00 |
| 02/28/2025 | Q4 | $2.3M | $1K | -$0.90 | -$0.84 | -$0.06 |
| 11/13/2024 | Q3 | $601.1K | $3K | -$0.79 | -$0.70 | -$0.09 |
| 08/08/2024 | Q2 | $685.7K | $5K | -$0.63 | -$0.71 | $0.08 |
| 05/09/2024 | Q1 | $915.7K | $28K | -$0.66 | -$0.76 | $0.10 |
| 02/29/2024 | Q4 | $2.4M | -$19K | -$0.77 | -$0.73 | -$0.04 |
| 11/09/2023 | Q3 | -- | -- | -$0.24 | -$0.60 | $0.36 |
| 08/09/2023 | Q2 | -- | -- | -$0.77 | -$0.77 | $0.00 |
| 05/10/2023 | Q1 | -- | -- | -$0.88 | -$0.90 | $0.02 |
| 03/15/2023 | Q4 | -- | -- | -$0.84 | -$0.73 | -$0.11 |
| 11/08/2022 | Q3 | -- | -- | -$0.79 | -$0.91 | $0.12 |
| 08/11/2022 | Q2 | -- | -- | -$0.87 | -$0.85 | -$0.02 |
| 05/12/2022 | Q1 | -- | -- | -$0.82 | -$0.77 | -$0.05 |
| 03/28/2022 | Q4 | -- | -- | -$0.85 | -$0.86 | $0.01 |
| 11/10/2021 | Q3 | -- | -- | -$0.82 | -$0.81 | -$0.01 |
| 08/12/2021 | Q2 | -- | -- | -$0.28 | -$0.68 | $0.40 |
| 05/13/2021 | Q1 | -- | -- | -$0.61 | -$1.10 | $0.49 |
| 03/25/2021 | Q4 | -- | -- | -$0.77 | -$0.66 | -$0.11 |
| 09/30/2020 | Q3 | -- | -- | -$0.36 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.89 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$1.09 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | -$1.12 | -- | -- |
4D Molecular Therapeutics Earnings Questions
-
How Much did 4D Molecular Therapeutics Generate in Revenue Last Quarter?
4D Molecular Therapeutics reported $14K worth of top line sales in its most recent quarter.
-
Did 4D Molecular Therapeutics Beat Earnings Last Quarter?
4D Molecular Therapeutics announced earnings per share of -$0.86 which represents a beat of analyst forecast a -$0.86 per share.
-
Is 4D Molecular Therapeutics Profitable?
4D Molecular Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for 4D Molecular Therapeutics EPS Next Year?
4D Molecular Therapeutics's earnings are forecast to decrease from -$2.98 per share to -$2.92 per share next year representing a decrease of -19.47%.
-
When is 4D Molecular Therapeutics's Earnings Date?
4D Molecular Therapeutics's next earnings date is August 8, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
72
SBET alert for Jul 18
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
